This site is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa logo

 

Agenda

Scientific and Academic

Hematology

Date: 9 July 2026 | Time: 9:20 – 12:15 | Room : Conference Room Hall 7 | Accreditation: CME 4.25 credits, CMTE credits

This track brings together laboratory specialists, hematologists, and pathology experts to explore how hematology practice is evolving from routine microscopy to more advanced molecular and immunohistochemical applications. The session is designed to connect practical diagnostic work with current clinical challenges, including blood film interpretation, pediatric bleeding disorders, transfusion support, and the diagnostic value of biomarkers in cytopenic patients.

Scientific Supporting Organization:

  • Royal College of Pathologists of Thailand 
  • Thai Society of Clinical Pathology 

Scientific Conference Chair:

  •  Phandee Watanaboonyongcharoen, M.D.
    Department of Laboratory Medicine, Faculty of Medicine, Chulalonkorn University

09:20 – 09:30

Opening Remark

Phandee Watanaboonyongcharoen, M.D.
Department of Laboratory Medicine, Faculty of Medicine, Chulalonkorn University, Chairperson of Hematology

09:30 – 10:00

TBA

10:00 – 10:30

Molecular and Genetic Insights in Pediatric Bleeding Disorders

Darintr Sosothikul, MD
Professor of Pediatrics, Chief, Hematology/ Oncology Division, Department of   Pediatrics, Head, Integrative and Innovative Hematology/Oncology Research unit, Faculty of Medicine, Chulalongkorn University

10:30 - 10:45

Break

10:45 – 11:45

The role of RBC genotype in transfusion medicine

Dr Yew-Wah Liew
Red Cell Reference Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia

11:45 – 12:15

Implication of p53 IHC in patients with cytopenia

Assistant Prof Kran Suknuntha, M.D., Ph.D

12:15 – 13:30

Lunch and Visit Exhibition

Infrastructure and Medical Device Administration (IMDA)

Agenda updated as of 15 May 2026